Rafael Blesa Gonzalez
Rafael Blesa Gonzalez
Servicio de Neurología - Hospital St Pau Barcelona
Verified email at santpau.cat
Cited by
Cited by
Rare coding variants in PLCG2, ABI3, and TREM2 implicate microglial-mediated innate immunity in Alzheimer's disease
R Sims, SJ Van Der Lee, AC Naj, C Bellenguez, N Badarinarayan, ...
Nature genetics 49 (9), 1373-1384, 2017
Clinical validity of the ‘mini-mental state’for Spanish speaking communities
R Blesa, M Pujol, M Aguilar, P Santacruz, I Bertran-Serra, G Hernández, ...
Neuropsychologia 39 (11), 1150-1157, 2001
Prevalence of amyloid PET positivity in dementia syndromes: a meta-analysis
R Ossenkoppele, WJ Jansen, GD Rabinovici, DL Knol, WM van der Flier, ...
Jama 313 (19), 1939-1950, 2015
Spanish multicenter normative studies (NEURONORMA project): Methods and sample characteristics
J Peña-Casanova, R Blesa, M Aguilar, N Gramunt-Fombuena, ...
Archives of Clinical Neuropsychology 24 (4), 307-319, 2009
Efficacy of Souvenaid in mild Alzheimer's disease: results from a randomized, controlled trial
P Scheltens, JWR Twisk, R Blesa, E Scarpini, CAF Von Arnim, A Bongers, ...
Journal of Alzheimer's Disease 31 (1), 225-236, 2012
Neurofascin IgG4 antibodies in CIDP associate with disabling tremor and poor response to IVIg
L Querol, G Nogales-Gadea, R Rojas-Garcia, J Diaz-Manera, J Pardo, ...
Neurology 82 (10), 879-886, 2014
Frontotemporal dementia and its subtypes: a genome-wide association study
R Ferrari, DG Hernandez, MA Nalls, JD Rohrer, A Ramasamy, JBJ Kwok, ...
The Lancet Neurology 13 (7), 686-699, 2014
sTREM 2 cerebrospinal fluid levels are a potential biomarker for microglia activity in early‐stage Alzheimer's disease and associate with neuronal injury markers
M Suárez‐Calvet, G Kleinberger, MÁ Araque Caballero, M Brendel, ...
EMBO molecular medicine 8 (5), 466-476, 2016
Reelin expression and glycosylation patterns are altered in Alzheimer’s disease
A Botella-López, F Burgaya, R Gavín, MS García-Ayllón, ...
Proceedings of the National Academy of Sciences 103 (14), 5573-5578, 2006
Genetic screening of Alzheimer's disease genes in Iberian and African samples yields novel mutations in presenilins and APP
RJ Guerreiro, M Baquero, R Blesa, M Boada, JM Brás, MJ Bullido, ...
Neurobiology of aging 31 (5), 725-731, 2010
Spanish Multicenter Normative Studies (NEURONORMA Project): norms for verbal fluency tests
J Peña-Casanova, S Quinones-Ubeda, N Gramunt-Fombuena, ...
Archives of Clinical Neuropsychology 24 (4), 395-411, 2009
Spanish multicenter normative studies (NEURONORMA Project): norms for the Rey–Osterrieth complex figure (copy and memory), and free and cued selective reminding test
J Peña-Casanova, N Gramunt-Fombuena, S Quiñones-Úbeda, ...
Archives of Clinical Neuropsychology 24 (4), 371-393, 2009
Dementia risk in Parkinson disease: disentangling the role of MAPT haplotypes
N Setó-Salvia, J Clarimón, J Pagonabarraga, B Pascual-Sedano, ...
Archives of neurology 68 (3), 359-364, 2011
Caregiver preference for rivastigmine patch relative to capsules for treatment of probable Alzheimer's disease
B Winblad, AK Kawata, KM Beusterien, SK Thomas, A Wimo, R Lane, ...
International Journal of Geriatric Psychiatry: A journal of the psychiatry …, 2007
Significant association between the tau gene A0/A0 genotype and Parkinson's disease
P Pastor, M Ezquerra, E Muñoz, MJ Martí, R Blesa, E Tolosa, R Oliva
Annals of Neurology: Official Journal of the American Neurological …, 2000
Sustained response to Rituximab in anti-AChR and anti-MuSK positive Myasthenia Gravis patients
I Illa, J Diaz-Manera, R Rojas-Garcia, J Pradas, A Rey, R Blesa, C Juarez, ...
Journal of neuroimmunology 201, 90-94, 2008
Glucocerebrosidase mutations confer a greater risk of dementia during Parkinson's disease course
N Setó‐Salvia, J Pagonabarraga, H Houlden, B Pascual‐Sedano, ...
Movement Disorders 27 (3), 393-399, 2012
Amyloid precursor protein metabolism and inflammation markers in preclinical Alzheimer disease
D Alcolea, P Martínez-Lage, P Sánchez-Juan, J Olazarán, C Antúnez, ...
Neurology 85 (7), 626-633, 2015
Confluence of α-synuclein, tau, and β-amyloid pathologies in dementia with Lewy bodies
M Colom-Cadena, E Gelpi, S Charif, O Belbin, R Blesa, MJ Martí, ...
Journal of Neuropathology & Experimental Neurology 72 (12), 1203-1212, 2013
Relationship between β-secretase, inflammation and core cerebrospinal fluid biomarkers for Alzheimer's disease
D Alcolea, M Carmona-Iragui, M Suárez-Calvet, MB Sánchez-Saudinós, ...
Journal of Alzheimer's Disease 42 (1), 157-167, 2014
The system can't perform the operation now. Try again later.
Articles 1–20